Breakpoints

121 Épisodes

1. #61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

   Publié: 19/08/2022
2. #60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

   Publié: 22/07/2022
3. #59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

   Publié: 15/07/2022
4. #58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

   Publié: 24/06/2022
5. #57 – Dosing Consult: Ceftriaxone

   Publié: 27/05/2022
6. #56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

   Publié: 15/04/2022
7. #55 – One World: Global Perspectives in Antimicrobial Stewardship

   Publié: 25/03/2022
8. #54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

   Publié: 18/03/2022
9. #53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

   Publié: 18/02/2022
10. #52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

    Publié: 28/01/2022
11. #51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

    Publié: 21/01/2022
12. #50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

    Publié: 17/12/2021
13. #49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

    Publié: 03/12/2021
14. #48 – Aligning Goals: Antibiotics in End of Life Care

    Publié: 19/11/2021
15. #47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

    Publié: 29/10/2021
16. #46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

    Publié: 22/10/2021
17. #45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

    Publié: 24/09/2021
18. #44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

    Publié: 17/09/2021
19. #43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

    Publié: 27/08/2021
20. #42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

    Publié: 20/08/2021